NATURE CELL BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2025-02-19 ms8000000750456545 来自上海

5

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2009-09-30 匿名用户

国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。

717 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-11-05 ms1000001788822131 来自上海

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：1.20投稿
2.21 修回（补充原始数据）
8.02 投回去
10.13 接受

37 0

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-04-17 无言独上西楼来自广东省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;铁死亡
经验分享：2023.06.22 投稿
2023.07.22 修回
2024.01.02 投回去
2023.03.13 接受

142 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-04-27 卡卡文来自山东省

无

111 0

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-01-16 ms9000002134929590 来自江苏省

投过去初审几天啊?

122 0

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-09-16 ruiruizheng123

我们的也已经发表了：）

537 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-27 Mia

如何提炼/撰写文章题目？

392 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2020-05-21 尊严

你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表::
我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表:
我们的也已经发表了：）

ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）

561 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252569, encodeId=fd9d2252569fc, content=5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8838224391, createdName=ms8000000750456545, createdTime=Wed Feb 19 01:37:14 CST 2025, time=2025-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=469303, encodeId=8fdd4693038d, content=国内最近几年发了不少文章。要求的水平与JCB差不多，有不少文章是因为投了Nature, Cell被拒后，改投这个杂志的。因此，竞争是比较激烈的，如果你投cell被拒可以考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=717, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 13:14:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235386, encodeId=38da22353867d, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：1.20投稿 2.21 修回（补充原始数据） 8.02 投回去 10.13 接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822131, createdTime=Tue Nov 05 23:40:32 CST 2024, time=2024-11-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2199002, encodeId=1cfa219900298, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;铁死亡 经验分享：2023.06.22 投稿 2023.07.22 修回 2024.01.02 投回去 2023.03.13 接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76587125, createdName=无言独上西楼, createdTime=Wed Apr 17 18:04:52 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200711, encodeId=e9302200e1174, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e15458021, createdName=卡卡文, createdTime=Sat Apr 27 14:46:46 CST 2024, time=2024-04-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182004, encodeId=000721820048a, content=投过去初审几天啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97a95469468, createdName=ms9000002134929590, createdTime=Tue Jan 16 16:45:38 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=576380, encodeId=61a25e6380b3, content=我们的也已经发表了：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=537, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c6c1714136, createdName=ruiruizheng123, createdTime=Mon Sep 16 08:46:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095631, encodeId=23591095631c8, content=如何提炼/撰写文章题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591441, encodeId=bac959144144, content=你们好厉害啊如果没有革命性的创新但是有3组cre 老鼠 3组knock in老鼠全面的机制实验有没有机会呢？ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）ruiruizheng123 2019-09-16 08:46:00 发表: 我们的也已经发表了：）, beContent=ruiruizheng123 2019-09-16 发表:: 我们的也已经发表了：）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544497, encodeId=5f2954449ec2, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=736, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 gu_8183

谁能预测明年会有多少分?

736 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务